Stockscreener 앱 받기
0.611
1.45%
-0.009
시간 외 거래:
.59
-0.021
-3.44%
전일 마감가:
$0.62
열려 있는:
$0.62
하루 거래량:
62,545
Relative Volume:
0.10
시가총액:
$3.16M
수익:
-
순이익/손실:
$-22.94M
주가수익비율:
-5.5545
EPS:
-0.11
순현금흐름:
$-15.50M
1주 성능:
-32.11%
1개월 성능:
-85.17%
6개월 성능:
+259.41%
1년 성능:
+160.44%
1일 변동 폭
$0.5538
$0.649
1주일 범위
$0.50
$0.9742
52주 변동 폭
$0.09
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
명칭
Matinas Biopharma Holdings Inc
전화
908-443-1860
주소
1545 Route 206 South, Suite 302, Bedminster, NJ
MTNB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| MTNB | 0.611 | 3.16M | 0 | -22.94M | -15.50M | -0.11 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-05-11 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | 재개 | Piper Sandler | Overweight |
| 2020-01-27 | 개시 | Piper Sandler | Overweight |
| 2020-01-24 | 개시 | SunTrust | Buy |
| 2020-01-23 | 개시 | SunTrust | Buy |
| 2020-01-09 | 개시 | Aegis Capital | Buy |
| 2019-06-26 | 개시 | H.C. Wainwright | Buy |
모두보기
Matinas Biopharma Holdings Inc 주식(MTNB)의 최신 뉴스
MTNB stock touches 52-week low at $0.5 amid sharp annual decline - Investing.com Australia
Maxim Group Reiterates Hold Rating for Matinas BioPharma (NYSEAMERICAN:MTNB) - Defense World
MTNBMatinas BioPharma Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Matinas BioPharma plunges as deal for lead asset falls apart - MSN
Matinas BioPharma mulls wind-down as antifungal therapy deal falls through - Pharmaceutical Technology
Matinas BioPharma stock falls on strategic options (MTNB:NYSE) - Seeking Alpha
Nasdaq Down Over 200 Points; Microsoft Shares Fall After Q1 Results - Benzinga
Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction - The Manila Times
Matinas BioPharma Announces the Termination of MAT2203 - GlobeNewswire
MTNB stock touches 52-week low at $2.87 amid market challenges - Investing.com Canada
MTNB stock touches 52-week low at $2.87 amid market challenges By Investing.com - Investing.com South Africa
Highbridge Capital Management's Strategic Acquisition in Matinas BioPharma - GuruFocus.com
MTNB stock touches 52-week low at $3.24 amid market challenges - Investing.com Australia
TMT Acquisition Corp Announces Changes to Contribution to Trust Account and the Use of Funds in Trust Account to Pay Dissolution Expenses in Connection with Extension Amendment Proposal - StockTitan
Mativ Holdings, Inc. Announces Pricing of Its $400 Million Offering of Senior Notes - Yahoo Finance
Checking in on Mattel, Inc. (MAT) after recent insiders movement - Knox Daily
TMT Acquisition Corp Announces Adjournment of Extraordinary General Meeting of Shareholders - StockTitan
68,521 Shares in Metals Acquisition Limited (NYSE:MTAL) Purchased by Rhumbline Advisers - Defense World
Mativ Holdings offers senior notes to finance existing debt - MSN
30 Shares in Mettler-Toledo International Inc. (NYSE:MTD) Acquired by Itau Unibanco Holding S.A. - Defense World
Clear Street LLC Reduces Holdings in TMT Acquisition Corp (NASDAQ:TMTC) - Defense World
Highbridge Capital Management LLC Takes $1.69 Million Position in Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB) - Defense World
Stock Analysts’ Downgrades for September 18th (ATNM, BHR, CALX, FITB, MEDP, MMSI, MOH, MTRX, NPK, PRMW) - Defense World
Mattel price returns higherForecast today18-09-2024 - Economies.com
Rhumbline Advisers Sells 3,565 Shares of Mativ Holdings, Inc. (NYSE:MATV) - Defense World
Brothers of 18-year-old killed outside Nashville club speak out against gun violence - WKRN News 2
One person shot after multiple people were fighting at Nashville gas station - News Channel 5 Nashville
Mattr sells Brazilian pipe coating business for US$17.5 million | 2024-09-16 | Investing News - Stockhouse Publishing
Implant maker Tenon Medical nearly triples its market capitalization in two days - Kursiv Media
At least 3 dead after overnight shooting in Antioch - Yahoo! Voices
Tenon Medical stock jumps 73% in wake of Nasdaq listing update (NASDAQ:TNON) - Seeking Alpha
Stocks of the Hour: Locksley Resources, MTM Critical Metals, Battery Age Minerals - Finance News Network
Matinas BioPharma (NYSEAMERICAN:MTNB) Shares Gap Up to $3.64 - Defense World
Towercrest Capital Management Invests $299,000 in Matinas BioPharma Holdings, Inc. (NYSEAMERICAN:MTNB) - MarketBeat
Matinas BioPharma (NYSEAMERICAN:MTNB) Shares Gap Down to $3.72 - MarketBeat
Matinas BioPharma Holdings (FRA:6LJ0) Net Income : €-21.22 Mil (TTM As of Jun. 2024) - GuruFocus.com
Matinas BioPharma (NYSEAMERICAN:MTNB) Hits New 12-Month Low at $3.77 - MarketBeat
Matinas BioPharma implements reverse stock split By Investing.com - Investing.com Australia
Matinas BioPharma (NYSEAMERICAN:MTNB) Shares Up 4,230.1% - MarketBeat
Matinas BioPharma implements reverse stock split - Investing.com
Matinas BioPharma stock hits 52-week low at $4.49 - Investing.com
MATINAS BIOPH. NEW O.N. Trade Ideas — FWB:6LJ0 - TradingView
Matinas BioPharma stock hits 52-week low at $4.49 By Investing.com - Investing.com Canada
Matinas BioPharma (NYSEAMERICAN:MTNB) Hits New 1-Year High at $4.67 - MarketBeat
Matinas BioPharma enacts reverse stock split - Investing.com
MTNB’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle
An analyst sees good growth prospects for Matinas Biopharma Holdings Inc (MTNB) - SETE News
Balance Sheet Dive: Matinas Biopharma Holdings Inc (MTNB)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Should investors be concerned about Matinas Biopharma Holdings Inc (MTNB)? - US Post News
Does Matinas Biopharma Holdings Inc (MTNB) offer a good opportunity for investors? - SETE News
Matinas Biopharma Holdings Inc (MTNB) Stock: A Year of Market Fluctuations - The InvestChronicle
Matinas Biopharma Holdings Inc (MTNB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.66%
1.11%
자본화:
|
볼륨(24시간):